CD200 靶点蛋白|抗体药物|临床药物信息

CD200信息

英文名称：OX-2 membrane glycoprotein
中文名称：OX-2膜糖蛋白
靶点别称：My033，CD200，CD200 Antigen，Antigen Identified By Monoclonal Antibody MRC OX-2，MOX1，OX-2 Membrane Glycoprotein，OX-2，MRC，CD200 Molecule，MOX2

上市药物数量：0
临床药物数量：1
最高研发阶段：临床一期

CD200产品列表

筛选结果

产品库

在线 (5)

物种

标签

属性

Protein (5)

标记

货号	物种	产品描述
OX2-H5228	Human	Human CD200 / OX-2 Protein, His Tag
OX2-H5251	Human	Human CD200 / OX-2 Protein, Fc Tag
OX2-H82F1	Human	Biotinylated Human CD200 / OX-2 Protein, Fc,Avitag™
OX2-H82F7	Human	Biotinylated Human CD200 / OX-2 Protein, Fc (L234A, L235A, P329G),Avitag™
OX2-M82F3	Mouse	Biotinylated Mouse CD200 / OX-2 Protein, Fc,Avitag™ (MALS verified)

CD200 分子别名

CD200,MOX1,MOX2,MRC,OX-2,My033

CD200 分子背景

CD200 is also known as OX-2 membrane glycoprotein (OX-2), is a type-1 membrane glycoprotein, which contains two immunoglobulin domains (1 Ig-like C2-type (immunoglobulin-like) domain and Ig-like V-type (immunoglobulin-like) domain), and thus belongs to the immunoglobulin superfamily. CD200 / OX-2 is widely expressed in multiple cell types. CD200 interacts with a structurally related receptor (CD200R) expressed mainly on myeloid cells and is involved in regulation of macrophage and mast cell function. OX-2 / CD200 and CD200R associate via their respective N-terminal Ig-like domains. CD200 also plays an important role in prevention of graft rejection, autoimmune diseases and spontaneous abortion.

CD200 前沿进展

CD200临床药物信息

英文名称	研发代码	研发阶段	公司	适应症	临床试验
CD-200-AR-L	CD-200-AR-L; hP-1-A-8	临床一期	University Of Minnesota	胶质母细胞瘤	详情

会议日历

会议一览

CD200